Mitroflow DL Post Approval Study- North America

NCT02351726 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

186

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor business decision

Conditions

Aortic Stenosis
Aortic Regurgitation
Aortic Valve Insufficiency
Heart Valve Diseases
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Heart Diseases
Pathological Conditions, Anatomical

Interventions

DEVICE: Mitroflow DL

Sponsor

LivaNova